Neonmind Biosciences Stock Number Of Shares Shorted
| NMDBFDelisted Stock | USD 0.50 0.00 0.00% |
NeonMind Biosciences fundamentals help investors to digest information that contributes to NeonMind Biosciences' financial success or failures. It also enables traders to predict the movement of NeonMind Pink Sheet. The fundamental analysis module provides a way to measure NeonMind Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NeonMind Biosciences pink sheet.
NeonMind |
NeonMind Biosciences Company Number Of Shares Shorted Analysis
NeonMind Biosciences' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, NeonMind Biosciences has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
NeonMind Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NeonMind Biosciences' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NeonMind Biosciences could also be used in its relative valuation, which is a method of valuing NeonMind Biosciences by comparing valuation metrics of similar companies.NeonMind Biosciences is currently under evaluation in number of shares shorted category among its peers.
NeonMind Fundamentals
| Return On Equity | -37.22 | |||
| Return On Asset | -1.88 | |||
| Operating Margin | 735.17 % | |||
| Current Valuation | 799.08 K | |||
| Shares Outstanding | 35.82 M | |||
| Price To Book | 12.19 X | |||
| Price To Sales | 18.10 X | |||
| Gross Profit | (84.45 K) | |||
| EBITDA | (6.65 M) | |||
| Net Income | (7.21 M) | |||
| Cash And Equivalents | 89.22 K | |||
| Total Debt | 450.01 K | |||
| Debt To Equity | 1.58 % | |||
| Current Ratio | 0.59 X | |||
| Book Value Per Share | (1.22) X | |||
| Cash Flow From Operations | (5.82 M) | |||
| Earnings Per Share | (0.14) X | |||
| Beta | -1.12 | |||
| Market Capitalization | 272.23 K | |||
| Total Asset | 1.34 M | |||
| Z Score | -13.2 | |||
| Net Asset | 1.34 M |
About NeonMind Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NeonMind Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeonMind Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeonMind Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in NeonMind Pink Sheet
If you are still planning to invest in NeonMind Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NeonMind Biosciences' history and understand the potential risks before investing.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |